KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

West Pharmaceutical Services (WST) Other Gross PP&E Adjustments (2016 - 2025)

West Pharmaceutical Services' Other Gross PP&E Adjustments history spans 17 years, with the latest figure at $3.1 billion for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 7.81% year-over-year to $3.1 billion; the TTM value through Dec 2025 reached $3.1 billion, up 7.81%, while the annual FY2025 figure was $3.1 billion, 7.81% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $3.1 billion at West Pharmaceutical Services, down from $3.2 billion in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $3.2 billion in Q3 2025 and bottomed at $2.0 billion in Q1 2021.
  • The 5-year median for Other Gross PP&E Adjustments is $2.5 billion (2023), against an average of $2.5 billion.
  • The largest annual shift saw Other Gross PP&E Adjustments rose 2.81% in 2022 before it increased 16.96% in 2023.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $2.1 billion in 2021, then grew by 6.36% to $2.3 billion in 2022, then grew by 15.63% to $2.6 billion in 2023, then rose by 9.19% to $2.9 billion in 2024, then grew by 7.81% to $3.1 billion in 2025.
  • Per Business Quant, the three most recent readings for WST's Other Gross PP&E Adjustments are $3.1 billion (Q4 2025), $3.2 billion (Q3 2025), and $3.1 billion (Q2 2025).